By expenditures
| Name | Title | Type |
|---|---|---|
| Bob Hasz | BUSINESS MANAGER | Auditee |
| Craig Popenhagen | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 328160 | 2024 | 2024-11-13 | Cliftonlarsonallen LLP | $1.13M |
| 11763 | 2023 | 2024-01-16 | Cliftonlarsonallen LLP | $1.25M |
| 49903 | 2022 | 2022-12-15 | Cliftonlarsonallen LLP | $2.02M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 328160 | 2024 | 2024-11-13 | 1081909 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 1081908 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 1081907 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 1081906 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 1081905 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 1081904 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 1081903 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 1081902 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 1081901 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 1081900 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 505467 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 505466 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 505465 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 505464 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 505463 | 2024-003 | Material Weakness | - | I |
| 328160 | 2024 | 2024-11-13 | 505462 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 505461 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 505460 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 505459 | 2024-002 | Significant Deficiency | - | I |
| 328160 | 2024 | 2024-11-13 | 505458 | 2024-002 | Significant Deficiency | - | I |